Sichuan Huiyu Pharmaceutical Co Ltd (688553) — Cash Flow Quality Index
Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a Cash Flow Quality Index of 1.96x as of September 2025. Operating cash flow of CN¥58.54 Million exceeds net income of CN¥29.92 Million, indicating high earnings quality where cash backs reported profits. Also explore 688553 total asset value for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sichuan Huiyu Pharmaceutical Co Ltd Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Sichuan Huiyu Pharmaceutical Co Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Sichuan Huiyu Pharmaceutical Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Sichuan Huiyu Pharmaceutical Co Ltd (2019–2024)
Year-by-year earnings quality comparison for Sichuan Huiyu Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Sichuan Huiyu Pharmaceutical Co Ltd (688553) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.77x | CN¥242.96 Million | CN¥315.90 Million | ▲ +60.6% |
| 2023 | 0.48x | CN¥66.93 Million | CN¥139.79 Million | ▼ -38.6% |
| 2022 | 0.78x | CN¥194.06 Million | CN¥248.99 Million | ▼ -22.1% |
| 2021 | 1.00x | CN¥446.36 Million | CN¥445.86 Million | ▼ -11.8% |
| 2020 | 1.13x | CN¥387.95 Million | CN¥341.82 Million | ▼ -38.5% |
| 2019 | 1.84x | CN¥326.22 Million | CN¥176.91 Million | — |